EUVIMEDEUVIMED entdecken
Crossref

Quantitative CZT SPECT Myocardial Blood Flow for Physiological Assessment and Risk Stratification of Cardiac Allograft Vasculopathy

Paul Hart iD, Anas Jawaid, Jeffrey Fitch iD, Natalia Aerton, Erin M Armenia, Maria L Mackin iD, Sneha Limaye, Steven Avino, Paul Blasio, Dillon J Dzikowicz iD, Paco E Bravo iD, Leway Chen iD und 1 weitere

Circulation: Cardiovascular Imaging · 2026-08 · 19 (8)

DOI: 10.1161/circimaging.126.019747 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Cardiovascular Imaging, 2026-08. Verfasst von Paul Hart und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Division, Department of Medicine (P.H., A.J., J.F., N.A., E.M.A., M.L.M., S.L., S.A., P.B., L.C., R.G.S.), University of Rochester, NY. Hauptthemen laut MEDLINE: Heart Transplantation, Tomography, Emission-Computed, Single-Photon, Myocardial Perfusion Imaging, Coronary Artery Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cardiac allograft vasculopathy (CAV) remains a major cause of morbidity and mortality after orthotopic heart transplantation. Although positron emission tomography myocardial perfusion imaging with quantitative myocardial blood flow (MBF) effectively detects CAV, access remains limited. Cadmium-zinc-telluride (CZT) single-photon emission computed tomography (SPECT) enables quantitative MBF assessment and may provide a more accessible alternative. However, the diagnostic and prognostic value of quantitative CZT SPECT-derived MBF for CAV is unknown. METHODS: We retrospectively studied 110 consecutive orthotopic heart transplantation recipients who underwent coronary angiography and CZT SPECT quantitative MBF imaging within 12 months. Stress MBF, rest MBF, MBF reserve, coronary flow capacity, and total perfusion deficit were compared across International Society for Heart and Lung Transplantation CAV categories. The diagnostic performance of the established (Bravo) and modified (Hart) flow-based algorithms was evaluated by receiver operating characteristic analysis. Associations with CAV-related events were assessed. RESULTS: Over 2.3±1.0 years, stress MBF declined progressively with increasing CAV severity ( P =0.007) and was lower in patients with CAV 2 to 3 than in those with CAV 0 to 1 (1.25±0.52 versus 2.03±0.81 mL/min per g; P =0.003). The Bravo and Hart algorithms showed similar discrimination of advanced CAV by paired DeLong comparison (area under the curve, 0.773 versus 0.717; Δ area under the curve, 0.056; P =0.606). Severely reduced coronary flow capacity was associated with higher event rates (28.6% versus 5.2%; P =0.015). The Hart framework demonstrated exploratory prognostic separation (35.3% versus 3.2%; P =0.001). CONCLUSIONS: Quantitative CZT SPECT-derived MBF and coronary flow capacity provide physiological assessment and risk stratification of CAV, with preliminary associations with CAV-related events. These findings support the prospective multicenter evaluation of CZT SPECT MBF as a widely available, noninvasive orthotopic heart transplantation surveillance strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationTomography, Emission-Computed, Single-PhotonMyocardial Perfusion ImagingCoronary Artery DiseaseCoronary CirculationZincCadmiumTelluriumCoronary VesselsHumansRetrospective StudiesFemaleMalePredictive Value of TestsRisk AssessmentMiddle AgedCoronary AngiographyRisk FactorsAllograftsSeverity of Illness IndexROC CurveTime FactorsTreatment OutcomeAged

Stichwörter der Autor:innen

coronary circulationcoronary diseaseheart transplantationmyocardial perfusion imagingradionuclide imagingrisk assessmenttomography, emission-computed, single-photon

Substanzen

ZincCadmiumTelluriumCdZnTe

Autor:innen und Institutionen

  • Cardiology Division, Department of Medicine (P.H., A.J., J.F., N.A., E.M.A., M.L.M., S.L., S.A., P.B., L.C., R.G.S.), University of Rochester, NY.
  • School of Nursing (D.J.D.), University of Rochester, NY.
  • Clinical Cardiovascular Research Center (D.J.D.), University of Rochester, NY.
  • Divisions of Nuclear Medicine, Departments of Radiology and Medicine, Cardiovascular Imaging and Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia (P.E.B.).
  • Division of Nuclear Medicine, Department of Imaging Sciences (R.G.S.), University of Rochester, NY.

ORCID-Profile: Paul Hart, Jeffrey Fitch, Maria L Mackin, Dillon J Dzikowicz, Paco E Bravo, Leway Chen, Ronald G Schwartz

Zitieren

APA

Hart, P., Jawaid, A., Fitch, J., Aerton, N., Armenia, E. M., Mackin, M. L., Limaye, S., Avino, S., Blasio, P., Dzikowicz, D. J., Bravo, P. E., Chen, L., & Schwartz, R. G. (2026). Quantitative CZT SPECT Myocardial Blood Flow for Physiological Assessment and Risk Stratification of Cardiac Allograft Vasculopathy. Circulation: Cardiovascular Imaging, 19(8). https://doi.org/10.1161/circimaging.126.019747

Vancouver

Hart P, Jawaid A, Fitch J, Aerton N, Armenia EM, Mackin ML, et al. Quantitative CZT SPECT Myocardial Blood Flow for Physiological Assessment and Risk Stratification of Cardiac Allograft Vasculopathy. Circulation: Cardiovascular Imaging. 2026;19(8). doi:10.1161/circimaging.126.019747

BibTeX
@article{Hart2026,
  author = {Hart, Paul and Jawaid, Anas and Fitch, Jeffrey and Aerton, Natalia and Armenia, Erin M and Mackin, Maria L and Limaye, Sneha and Avino, Steven and Blasio, Paul and Dzikowicz, Dillon J and Bravo, Paco E and Chen, Leway and Schwartz, Ronald G},
  title = {Quantitative CZT SPECT Myocardial Blood Flow for Physiological Assessment and Risk Stratification of Cardiac Allograft Vasculopathy},
  journal = {Circulation: Cardiovascular Imaging},
  year = {2026},
  volume = {19},
  number = {8},
  doi = {10.1161/circimaging.126.019747}
}
Kostenlos starten →